Mumbai, Apr 28 (ANI/Business Wire India): GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the first quarter ended March 31. The Company has posted a net sales growth of 9.3 per cent compared to the previous quarter, while Profit Before Tax has grown by 7.9 percent, on a comparable basis.
Commenting on the performance during the quarter, Dr. Hasit B. Joshipura, Managing Director, said, "The Company's major products in the Priority range, including vaccines, registered good growth.
During the quarter under review, we launched Cervarix, our vaccine for protecting women against Cervical Cancer and the initial response for the same has been encouraging". (ANI)